|
1
|
Loftus EV Jr: Clinical epidemiology of
inflammatory bowel disease: Incidence, prevalence, and
environmental influences. Gastroenterology. 126:1504–1517. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xavier RJ and Podolsky DK: Unravelling the
pathogenesis of inflammatory bowel disease. Nature. 448:427–434.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abreu MT: Toll-like receptor signalling in
the intestinal epithelium: how bacterial recognition shapes
intestinal function. Nat Rev Immunol. 10:131–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Akira S and Takeda K: Toll-like receptor
signalling. Nat Rev Immunol. 4:499–511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Szebeni B, Veres G, Dezsofi A, Rusai K,
Vannay A, Bokodi G, Vásárhelyi B, Korponay-Szabó IR, Tulassay T and
Arató A: Increased mucosal expression of Toll-like receptor (TLR)2
and TLR4 in coeliac disease. J Pediatr Gastroenterol Nutr.
45:187–193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Frolova L, Drastich P, Rossmann P,
Klimesova K and Tlaskalova-Hogenova H: Expression of Toll-like
receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients
with inflammatory bowel diseases: upregulated expression of TLR2 in
terminal ileum of patients with ulcerative colitis. J Histochem
Cytochem. 56:267–274. 2008. View Article : Google Scholar
|
|
7
|
Chen LW, Chang WJ, Chen PH, Liu WC and Hsu
CM: TLR ligand decreases mesenteric ishcemia and reperfusion
injury-induced gut damage through TNF-alpha signaling. Shock.
30:563–570. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berkowitz D, Peri R, Lavy A and Kessel A:
Increased Toll-like receptor 9 expression by B cells from
inflammatory bowel disease patients. Hum Immunol. 74:1519–1523.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Erridge C, Duncan SH, Bereswill S and
Heimesaat MM: The induction of colitis and ileitis in mice is
associated with marked increases in intestinal concentrations of
stimulants of TLRs 2, 4, and 5. PLoS One. 5:e91252010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Paiva NM, Ayrizono ML, Milanski M,
Coope A, Oliveira LM, Fagundes JJ, Velloso LA, Coy CS and Leal RF:
Differential expression of TLR2, TLR4 and JNK in mucosa of ileal
pouches for ulcerative colitis. Is there a role for bacterial
antigen pathway in asymptomatic patients? Int J Clin Exp Med.
4:179–186. 2011.PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
12
|
Geremia A, Biancheri P, Allan P, Corazza
GR and Sabatino A: Innate and adaptive immunity in inflammatory
bowel disease. Autoimmun Rev. 13:3–10. 2014. View Article : Google Scholar
|
|
13
|
Mayer L, Eisenhardt D, Salomon P, Bauer W,
Plous R and Piccinini L: Expression of class II molecules on
intestinal epithelial cells in humans. Gastroenterology. 100:3–12.
1991.PubMed/NCBI
|
|
14
|
Gomez CR, Boehmer ED and Kovacs EJ: The
aging innate immune system. Curr Opin Immunol. 17:457–462. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lavelle EC, Murphy C, O’Neill LA and
Creagh EM: The role of TLRs, NLRs, and RLRs in mucosal innate
immunity and homeostasis. Mucosal Immunol. 3:17–28. 2010.
View Article : Google Scholar
|
|
16
|
Cario E, Rosenberg IM, Brandwein SL, Beck
PL, Reinecker HC and Podolsky DK: Lipopoly-saccharide activates
distinct signaling pathways in intestinal epithelial cell lines
expressing Toll-like receptors. J Immunol. 164:966–972. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cario E and Podolsky DK: Differential
alteration in intestinal epithelial cell expression of toll-like
receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect
Immun. 68:7010–7017. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hausmann M, Kiessling S, Mestermann S,
Webb G, Spöttl T, Andus T, Schölmerich J, Herfarth H, Ray K, Falk W
and Rogler G: Toll-like receptors 2 and 4 are up-regulated during
intestinal inflammation. Gastroenterology. 122:1987–2000. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Toiyama Y, Araki T, Yoshiyama S, Hiro J,
Miki C and Kusunoki M: The expression patterns of Toll-like
receptors in the ileal pouch mucosa of postoperative ulcerative
colitis patients. Surg Today. 36:287–290. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gewirtz AT, Navas TA, Lyons S, Godowski PJ
and Madara JL: Cutting edge: bacterial flagellin activates
basolaterally expressed TLR5 to induce epithelial proinflammatory
gene expression. J Immunol. 167:1882–1885. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gewirtz AT, Simon PO Jr, Schmitt CK,
Taylor LJ, Hagedorn CH, O’Brien AD, Neish AS and Madara JL:
Salmonella typhimurium translocates flagellin across intestinal
epithelia, inducing a proinflammatory response. J Clin Invest.
107:99–109. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xavier RJ and Podolsky DK: Microbiology.
How to get along - friendly microbes in a hostile world. Science.
289:1483–1484. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shaykhiev R, Behr J and Bals R: Microbial
patterns signaling via Toll-like receptors 2 and 5 contribute to
epithelial repair, growth and survival. PLoS One. 3:e13932008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pedersen G, Andresen L, Matthiessen MW,
Rask-Madsen J and Brynskov J: Expression of Toll-like receptor 9
and response to bacterial CpG oligodeoxynucleotides in human
intestinal epithelium. Clin Exp Immunol. 141:298–306. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Asselin-Paturel C and Trinchieri G:
Production of type I interferons: plasmacytoid dendritic cells and
beyond. J Exp Med. 202:461–465. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hall JA, Bouladoux N, Sun CM, Wohlfert EA,
Blank RB, Zhu Q, Grigg ME, Berzofsky JA and Belkaid Y: Commensal
DNA limits regulatory T cell conversion and is a natural adjuvant
of intestinal immune responses. Immunity. 29:637–649. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee J, Rachmilewitz D and Raz E:
Homeostatic effects of TLR9 signaling in experimental colitis. Ann
NY Acad Sci. 1072:351–355. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ewaschuk JB, Backer JL, Churchill TA,
Obermeier F, Krause DO and Madsen KL: Surface expression of
Toll-like receptor 9 is upregulated on intestinal epithelial cells
in response to pathogenic bacterial DNA. Infect Immun.
75:2572–2579. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ghadimi D, Vrese M, Heller KJ and
Schrezenmeir J: Effect of natural commensal-origin DNA on toll-like
receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and
barrier integritiy of polarized intestinal epithelial cells.
Inflamm Bowel Dis. 16:410–427. 2010. View Article : Google Scholar
|
|
30
|
Lee J, Mo JH, Katakura K, Alkalay I,
Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S, Kagnoff
M, Eckmann L, Ben-Neriah Y and Raz E: Maintenance of colonic
homeostasis by distinctive apical TLR9 signalling in intestinal
epithelial cells. Nat Cell Biol. 8:1327–1336. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Akhtar M, Watson JL, Nazli A and McKay DM:
Bacterial DNA evokes epithelial IL-8 production by a
MAPK-dependent, NF-kappaB-independent pathway. FASEB J.
17:1319–1321. 2003.PubMed/NCBI
|
